Neoantigen-specific T Cell Activation (N/A)

Neoantigen-specific T cell activation is the process by which T cells recognize and respond to tumor-derived neoantigens presented on MHC molecules. This activation leads to targeted killing of tumor cells and is a central mechanism in cancer immunotherapy. The process involves recognition of neoantigen-MHC complexes by the TCR, followed by T cell activation, proliferation, and effector function. Biomarkers like IFN-γ secretion and surface marker expression are used to identify and characterize activated neoantigen-specific T cells. Neoantigen-targeted therapies leverage this specificity for personalized cancer treatment.

Other names

Tumor-specific T cell responseNeoantigen recognitionAnti-tumor T cell immunity

T cell receptor (TCR) recognition of neoantigen-MHC complexes leading to T cell activation, proliferation, and cytotoxicity.